Gland Pharma Ltd
₹1844.20
as on
Gland Pharma Stock Performance
as on May 13, 2026 at 9:31 pm IST
Day's Low
Day's High
₹1,813.00₹1,872.10
1.69%
Downside
1.51%
Upside
52 Week's Low
52 Week's High
₹1,384.40₹2,131.0024.93%
Downside
15.55%
Upside
Gland Pharma share price movements today
- Previous Close
- ₹1,872.10
- Open
- ₹1,870.00
- Volume
- 1.00L
- Upper Circuit
- ₹2,246.50
- Lower Circuit
- ₹1,497.70
- Day's Low - High
- ₹1,813.00 - ₹1,872.10
- 52 Week Low - High
- ₹1,384.40 - ₹2,131.00
Gland Pharma Historical Returns
- 1 Month Return
- + 8.57 %
- 3 Month Return
- + 5.13 %
- 1 Year Return
- + 30.62 %
- 3 Year Return
- + 36.6 %
- 5 Year Return
- -34.66 %
Gland Pharma Fundamentals
as on May 13, 2026 at 4:01 pm IST
Market Cap
₹30,844.05 Cr
Return on Equity (ROE)
11.62
PE Ratio (TTM)
36.41
Return on capital employed (ROCE)
15.83
Industry PE ratio
45.31
Beta (LTM)
0.73
P/B Ratio
2.69
Dividend Yield
1.13
PEG Ratio
4.2
Quarterly Earnings Growth YOY
27.74
EPS (TTM)
42.4
Sector
Pharmaceuticals
Book Value
555.4
Gland Pharma Stock Valuation
as on May 13, 2026 at 4:01 pm IST
Gland Pharma in the last 5 years
Lowest (18.84x)
May 22, 2023
Today (36.41x)
May 12, 2026
Industry (45.31x)
May 12, 2026
Highest (67.14x)
August 12, 2021
Today’s Price to Earnings Ratio: 36.41x
Gland Pharma Technical Analysis
Track how Gland Pharma technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | -1.27 | |
CCI (20) | -95.67 | Neutral |
RSI (14) | 42.57 | Neutral |
Momentum (10) | -5.3 | |
ADI (14) | 19.53 | Neutral |
Ultimate Oscillator (7,14,28) | 48.63 | Neutral |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 1843.92 | |
EMA (20) | 1843.82 | |
VWMA (20) | 1843.38 | |
SMA (50) | 1846.7 | |
EMA (50) | 1844.84 | |
SMA (200) | 1833 | Bullish |
EMA (200) | 1839.01 | Bullish |
KAMA (200) | 1845.9 | |
DEMA (200) | 1840.51 | Bullish |
Gland Pharma Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Gland Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 30,844.05 | -6.93% | 0.53 | 698 | 5,616 | |
| BUY | 1,76,377.32 | 13.05% | 0.50 | 2,191 | 9,360 | |
| BUY | 1,48,303.41 | 44.39% | 0.66 | 1,911 | 11,516 | |
| BUY | 65,233.43 | 0.7% | 0.78 | 1,429 | 15,261 | |
| BUY | 1,04,389.75 | 8.59% | 0.51 | 5,291 | 27,547 |
Market expectation of Gland Pharma Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
60.00%
Buy
13.33%
Hold
26.67%
Sell
Gland Pharma Stock’s Investor Sentiment and Interest
Search interest for Gland Pharma Ltd Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Gland Pharma Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Gland Pharma Ltd Annual Profit & Loss
Figures in Rupees Crores
Gland Pharma Ltd Cash Flow
Figures in Rupees Crores
Gland Pharma Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Gland Pharma Stock
Check out the Mutual Funds with significant holdings in Gland Pharma.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 HDFC Mid Cap Fund -Direct Plan - Growth Option | 1.26% | 6317814 | |
 Mirae Asset Large & Midcap Fund Direct Plan Growth | 1.47% | 3301033 | |
 SBI Large & Midcap Fund Direct Growth | 1.44% | 3170000 | |
 ICICI Prudential India Opportunities Fund Direct Growth | 1.6% | 3099544 | |
 Nippon India Growth Mid Cap Fund - Direct Plan - Growth Mid Cap | 1.07% | 2800000 |
Gland Pharma Corporate Actions
View detailed summary of the earnings and dividend history of Gland Pharma.
Gland Pharma Ltd Earnings Results
Gland Pharma Ltd’s net profit jumped 27.74% since last year same period to ₹261.48Cr in the Q3 2025-2026. On a quarterly growth basis, Gland Pharma Ltd has generated 42.36% jump in its net profits since last 3-months.
Read More about Earnings ResultsGland Pharma Ltd Dividends May,2025
In the quarter ending March 2025, Gland Pharma Ltd has declared dividend of ₹18.00 per share on 20 May 2025 - translating a dividend yield of 2.03%.
Read More about Dividends
Indices Featuring Gland Pharma Stock
Check stock indices that include Gland Pharma.
Insights on Gland Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 183.68 Cr → 261.48 Cr (in ₹), with an average increase of 29.8% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, GLAND stock has moved up by 3.4%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 31.42% to 31.78% in Mar 2026 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 5 quarters, 1.44K Cr → 1.75K Cr (in ₹), with an average increase of 4.8% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 35.4% return, outperforming this stock by 4.8%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 51.83% of holdings in Mar 2026 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 163.0% return, outperforming this stock by 126.4%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 7.61% to 7.52% in Mar 2026 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 7.58% to 7.30% in Mar 2026 quarter
About Gland Pharma Ltd
Gland Pharma's operations include the development, manufacture, and marketing of a wide range of injectable drugs and active pharmaceutical ingredients. The company's product portfolio includes antibiotics, anti-emetics, anti-diabetics, anti-epileptics, and other therapeutic categories. Its top products include cephalosporins, penicillins, and other injectable antibiotics.
Gland Pharma is well known for its popular brands, such as Cephalosporin, Penicillin, and Amikacin. These brands have been widely used in hospitals and clinics across India, as well as in other countries. In addition, the company has developed and launched a wide range of generic and branded injectables, including Cefazolin, Cefuroxime, and Amikacin.
Revenue: ₹1,695.36Cr as on December 2025 (Q3 FY26)
Net Profit: ₹261.48Cr as on December 2025 (Q3 FY26)
Listing date: 20 Nov, 2020
Chairperson Name: Yiu Kwan Stanley Lau
| Organisation | Gland Pharma Ltd |
| Industry | Pharmaceuticals |
| CEO | Yiu Kwan Stanley Lau |
| E-voting on shares | Click here to vote |
FAQs
What is Gland Pharma share price today?
Gland Pharma share price today stands at ₹1844.2 as on at the close of the market. Gland Pharma share today touched a day high of ₹1872.1 and a low of ₹1813.
What is the 52 week high and 52 week low range for Gland Pharma share?
Gland Pharma touched a 52 week high of ₹2131 and a 52 week low of ₹1384.4. Gland Pharma share price today i.e. is closed at ₹1844.2, which is -13.46% down from its 52 week high and 33.21% up from its 52 week low.
What is Gland Pharma's market capitalisation today?
Gland Pharma market capitalisation is ₹30,844.05 Cr as on .
How to buy Gland Pharma shares?
To buy Gland Pharma shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for GLAND or Gland Pharma Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Gland Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Gland Pharma trading volume today?
Gland Pharma trading volume is 1.00L as on . This means that 1.00L shares of Gland Pharma were bought and sold on the stock market during today's trading session.